
|
|
![]() | ![]() | ![]() | ![]() |




Suggest other news sources for this topic

WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/c/ce/IPO.jpg': No such file or directory @ blob.c/OpenBlob/2480. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/c/ce/IPO.jpg/40px-IPO.jpg' @ convert.c/ConvertImageCommand/2800. |
This company completed an initial public offering (IPO) of its stock in 2010. View articles that reference this company. Recent IPOs: Globe Specialty Metals LogMeIn Invesco Mortgage Capital Medidata Chemspec |
DynaVox (DVOX) (NASDAQ:DVOX) manufactures speech-generating devices for people with disabilities such as ALS (Lou Gehrig's Disease), strokes, brain trauma, cerebral palsy, and others. Each year about 350,000 individuals join the group of people whom need the device. However, due to the low level of market awareness, only a few purchase it each year. The device is a digitized speech that allows people to communicate more clearly. The company also provides software for special education teachers to help students with speech impediments. [1]
According to Center for Disease Control, around 20 million adults and children in the United States suffer from conditions that could lead to speech impairment, and it is estimated 1.1 million are diagnosed with this condition every year. With these benchmarks, the company estimates a market opportunity of $1.8 billion from just the new cases. [1]
Since this is a medical device, insurance companies have to approve the device before it reaches the patient. If there were any legal changes that reduced funding for the device or denied coverage for the products, the company would face a major obstacle. [1]
The company's initial public offering of stock filed on the NASDAQ exchange on 5 January 2010. The proposed offer price range is $15.00-$17.00. The company is offering 9.4 million shares and raising $150 million. [1]
For FY2009 with year-ended 3 July 2009, the company reported net sales of $91.2 million, up 12% from $81.4 million in net sales in FY2008. Furthermore, the company had a net income of $8.84 million in FY2009, up 21.8% from $7.26 million of net income in FY2008. The speech devices accounted for 82% of net sales, and the software accounted for 18% of net sales. [1]
ReferencesCategories: Topic | IPO | NASDAQ | Services | Pharma & Healthcare



| |||||||